Browse Category

Mergers & Acquisitions 26 December 2025 - 30 December 2025

DigitalBridge stock jumps nearly 10% on SoftBank’s $4 billion buyout offer — what investors watch next

DigitalBridge stock jumps nearly 10% on SoftBank’s $4 billion buyout offer — what investors watch next

DigitalBridge Group, Inc. shares jumped 9.7% to $15.27 on Monday after SoftBank Group said it would buy the digital infrastructure investor for about $4 billion, or $16 a share in cash. SoftBank said the offer represents a 15% premium to DigitalBridge’s Dec. 26 close and about 50% to the stock’s “unaffected” 52-week average closing price as of Dec. 4. About 86 million shares changed hands, far above recent averages. Nasdaq+1
30 December 2025
···
JNJ stock today: J&J closes $3.05B Halda cancer deal, flags EPS hit — what’s next

JNJ stock today: J&J closes $3.05B Halda cancer deal, flags EPS hit — what’s next

Johnson & Johnson shares were last down 0.02% at $207.56 on Monday after the healthcare conglomerate said it completed its $3.05 billion cash acquisition of cancer drug developer Halda Therapeutics. The stock traded between $207.31 and $209.46, and J&J said it will account for the deal as a business combination and expects it to cut adjusted earnings per share by about $0.20, split evenly between the fourth quarter and 2026. JNJ.com
30 December 2025
····
ServiceNow (NOW) Stock Weekend Update: What Wall Street Is Watching After the $7.75B Armis Deal, CEO Contract Extension, and Fresh Analyst Targets

ServiceNow (NOW) Stock Weekend Update: What Wall Street Is Watching After the $7.75B Armis Deal, CEO Contract Extension, and Fresh Analyst Targets

ServiceNow, Inc. heads into the final trading stretch of the year with investors still digesting a major strategic pivot: a blockbuster cybersecurity acquisition, a growing list of deals across 2025, and new signals from Wall Street about how much of that M&A premium the market is willing to pay. Reuters+1
28 December 2025
··
ServiceNow (NOW) Stock Today: Analyst Price Targets, Armis Deal Digest, and What to Watch Before Monday’s Open

ServiceNow (NOW) Stock Today: Analyst Price Targets, Armis Deal Digest, and What to Watch Before Monday’s Open

ServiceNow, Inc. stock is heading into the final stretch of 2025 with Wall Street balancing two competing narratives: a year-end equity backdrop still hovering near record territory, and company-specific debate over whether ServiceNow’s cybersecurity expansion—led by its planned Armis acquisition—adds durable growth or introduces execution and financing risk.
27 December 2025
··
WBD Stock Update: Warner Bros. Discovery Shares Hover Near $29 as Netflix Deal, Paramount Bid, and Antitrust Risk Shape the Trade

WBD Stock Update: Warner Bros. Discovery Shares Hover Near $29 as Netflix Deal, Paramount Bid, and Antitrust Risk Shape the Trade

NEW YORK — Dec. 26, 2025 — Warner Bros. Discovery, Inc. Series A Common Stock is heading into the final trading days of the year with a rare combination of forces driving the price: a signed, headline-grabbing deal for its studios and streaming business, a hostile all-cash counterbid for the whole company, and a regulatory review that could determine whether any of it actually closes. Nasdaq
27 December 2025
····
Netflix Stock (NFLX) Today: Shares Tick Higher as Wall Street Weighs Warner Bros. Deal Financing, Regulatory Risk, and Q4 Earnings Ahead

Netflix Stock (NFLX) Today: Shares Tick Higher as Wall Street Weighs Warner Bros. Deal Financing, Regulatory Risk, and Q4 Earnings Ahead

As of 1:05 p.m. ET in New York on Friday, December 26, 2025, Netflix, Inc. is trading at $94.22, up about 0.6% on the day in a quiet, post-holiday session. The broader tape is mixed: the S&P 500 ETF is fractionally lower while the Nasdaq-100 ETF is roughly flat—typical of thin year-end trading where stock-specific headlines can matter more than macro catalysts.
26 December 2025
···
1 2 3 … 20
Follow on Google News
Add as preferred source Open in Google News
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 BUY ON PULLBACK

Microsoft

NASDAQ: MSFT 94 / 100
#2 BUY

L3Harris Technologies

NYSE: LHX 90 / 100
#3 BUY

Xylem

NYSE: XYL 89 / 100
#4 BUY IN TRANCHES

Lam Research

NASDAQ: LRCX 87 / 100
#5 BUY ON WEAKNESS

GE HealthCare

NASDAQ: GEHC 84 / 100
View full portfolio
Editorial model selection. Not personalised advice.